Francis Hubler
19Patents
5h-index
19Co-inventors
59Inventor score
Filing activity: Apr 22, 2002 → Jan 18, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8518912B2 | Phosphonic acid derivates and their use as P2Y12 receptor antagonists | Chemistry; Metallurgy | 9 | Active |
| US8048881B2 | Pyrimidine derivatives and their use as P2Y12 receptor antagonists | Chemistry; Metallurgy | 9 | Active |
| US8058263B2 | Substituted 2-phenyl-pyridine derivatives | Human Necessities | 7 | Active |
| US8288385B2 | 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines | Human Necessities | 7 | Active |
| US8202885B2 | Bridged six-membered ring compounds | Chemistry; Metallurgy | 5 | Active |
| US8664203B2 | Thiazole derivatives and their use as P2Y12 receptor antagonists | Chemistry; Metallurgy | 4 | Active |
| US9221832B2 | Heterocyclic amide derivatives as P2X7 receptor antagonists | Chemistry; Metallurgy | 4 | Active |
| US6995139B2 | Cyclic undecapeptide pro-drugs and uses thereof | Human Necessities | 3 | Expired |
| US8492555B2 | Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester | Human Necessities | 1 | Active |
| US11685729B2 | C5a receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US8436205B2 | Tetrahydronaphthalene compounds | Chemistry; Metallurgy | 0 | Active |
| US9556117B2 | Indole carboxamide derivatives as P2X7 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US11739070B2 | C5A receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US9388197B2 | Heterocyclic amide derivatives as P2X7 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US9718774B2 | Indole carboxamide derivatives as P2X7 receptor antagonist | Chemistry; Metallurgy | 0 | Active |
| US9388198B2 | Heterocyclic amide derivatives as P2X7 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US9409917B2 | Heterocyclic amide derivatives as P2X7 receptor antagonists | Human Necessities | 0 | Active |
| US8314253B2 | Bridged tetrahydronaphthalene derivatives | Human Necessities | 0 | Active |
| US11608341B2 | Substituted tetrahydropyrazolo[3,4-d]pyrimidines and tetrahydropyrazolo[4,3-d]pyrimidines as C5A receptor modulators | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.